These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of tissue factor is associated with clinical features and angiogenesis in prostate cancer. Ohta S; Wada H; Nakazaki T; Maeda Y; Nobori T; Shiku H; Nakamura S; Nagakawa O; Furuya Y; Fuse H Anticancer Res; 2002; 22(5):2991-6. PubMed ID: 12530031 [TBL] [Abstract][Full Text] [Related]
3. Angiogenesis and prostate cancer: identification of a molecular progression switch. Huss WJ; Hanrahan CF; Barrios RJ; Simons JW; Greenberg NM Cancer Res; 2001 Mar; 61(6):2736-43. PubMed ID: 11289156 [TBL] [Abstract][Full Text] [Related]
4. Tissue factor and VEGF expression in prostate carcinoma: a tissue microarray study. Yao JL; Ryan CK; Francis CW; Kohli M; Taubman MB; Khorana AA Cancer Invest; 2009 May; 27(4):430-4. PubMed ID: 19219655 [TBL] [Abstract][Full Text] [Related]
5. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease. Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844 [TBL] [Abstract][Full Text] [Related]
6. Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer. Stefanou D; Batistatou A; Kamina S; Arkoumani E; Papachristou DJ; Agnantis NJ In Vivo; 2004; 18(2):155-60. PubMed ID: 15113042 [TBL] [Abstract][Full Text] [Related]
7. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer. Gravdal K; Halvorsen OJ; Haukaas SA; Akslen LA Cancer Res; 2009 Jun; 69(11):4708-15. PubMed ID: 19487287 [TBL] [Abstract][Full Text] [Related]
8. Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma. Strohmeyer D; Strauss F; Rössing C; Roberts C; Kaufmann O; Bartsch G; Effert P Anticancer Res; 2004; 24(3a):1797-804. PubMed ID: 15274358 [TBL] [Abstract][Full Text] [Related]
9. Tumor angiogenesis is associated with MUC1 overexpression and loss of prostate-specific antigen expression in prostate cancer. Papadopoulos I; Sivridis E; Giatromanolaki A; Koukourakis MI Clin Cancer Res; 2001 Jun; 7(6):1533-8. PubMed ID: 11410487 [TBL] [Abstract][Full Text] [Related]
10. [Correlation of tissue factor expression to angiogenesis of gastric carcinoma and its clinical significance]. Jiao ZY; Gou CZ; Cao N; Li YM Ai Zheng; 2005 Jul; 24(7):880-4. PubMed ID: 16004820 [TBL] [Abstract][Full Text] [Related]
11. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739 [TBL] [Abstract][Full Text] [Related]
12. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression. Shang ZJ; Li JR J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226 [TBL] [Abstract][Full Text] [Related]
13. Independent association of angiogenesis index with outcome in prostate cancer. Mehta R; Kyshtoobayeva A; Kurosaki T; Small EJ; Kim H; Stroup R; McLaren CE; Li KT; Fruehauf JP Clin Cancer Res; 2001 Jan; 7(1):81-8. PubMed ID: 11205922 [TBL] [Abstract][Full Text] [Related]
14. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma. Poon RT; Lau CP; Ho JW; Yu WC; Fan ST; Wong J Clin Cancer Res; 2003 Nov; 9(14):5339-45. PubMed ID: 14614019 [TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate. Ravindranath N; Wion D; Brachet P; Djakiew D J Androl; 2001; 22(3):432-43. PubMed ID: 11330643 [TBL] [Abstract][Full Text] [Related]
16. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor. Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105 [TBL] [Abstract][Full Text] [Related]
17. Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model. Cheng L; Zhang S; Sweeney CJ; Kao C; Gardner TA; Eble JN Anticancer Res; 2004; 24(4):2135-40. PubMed ID: 15330153 [TBL] [Abstract][Full Text] [Related]
18. The expression of basic fibroblast growth factor and vascular endothelial growth factor in prostatic adenocarcinoma: correlation with neovascularization. Sugamoto T; Tanji N; Sato K; Fujita H; Nishio S; Sakanaka M; Yokoyama M Anticancer Res; 2001; 21(1A):77-88. PubMed ID: 11299793 [TBL] [Abstract][Full Text] [Related]
19. Expression of thymidine phosphorylase correlates with microvessel density in prostate cancer. Kataoka A; Yuasa T; Kageyama S; Iwaki H; Higuchi K; Tanaka T; Okada Y; Yoshiki T Oncol Rep; 2005 Apr; 13(4):597-600. PubMed ID: 15756429 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma? Moon WS; Rhyu KH; Kang MJ; Lee DG; Yu HC; Yeum JH; Koh GY; Tarnawski AS Mod Pathol; 2003 Jun; 16(6):552-7. PubMed ID: 12808060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]